Clincosm LogoSign in Get a demo

Disease Modifying Genes in Severe Asthma

Sponsor
NYU Langone Health (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT00212537
Collaborator
(none)
2,000
Enrollment
1
Location
240.8
Anticipated Duration (Months)
8.3
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Gene and protein bank to study disease modifying and susceptibility genes and proteins in urban patients with asthma.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    2000 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Other
    Official Title:
    Disease Modifying Genes in Severe Asthma
    Actual Study Start Date :
    Apr 8, 2002
    Actual Primary Completion Date :
    Jan 13, 2011
    Anticipated Study Completion Date :
    May 1, 2022

    Outcome Measures

    Primary Outcome Measures

    1. To recruit and characterize a cohort of subjects with asthma who reside in a high pollution, high asthma risk neighborhood [five yeARS]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Ages 18 and above
    Exclusion Criteria:

    • Greater than 10 pack year tobacco history

    • Lung diseases other than asthma

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 NYU School of Medicine New York New York United States 10016

    Sponsors and Collaborators

    • NYU Langone Health

    Investigators

    • Principal Investigator: Joan Reibman, MD, NYU School of Medicine

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    NYU Langone Health
    ClinicalTrials.gov Identifier:
    NCT00212537
    Other Study ID Numbers:
    • H9698
    First Posted:
    Sep 21, 2005
    Last Update Posted:
    Jan 26, 2022
    Last Verified:
    Jan 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by NYU Langone Health
    Asthma and normal
    Additional relevant MeSH terms:
    Asthma

    Study Results

    No Results Posted as of Jan 26, 2022